Cabometyx
Drug timelines are a Plus or Pro feature.
55 regulatory and trial events tracked for Cabometyx, covering 2016-04-25 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study [Phase 3]